Exhibit 1.1
Common Stock
($0.001 par value)
UNDERWRITING AGREEMENT
[Date]
To the Representatives
named in Schedule I
hereto of the Underwriters
named in Schedule II hereto
[Address]
Ladies and Gentlemen:
Aphton Corporation, a Delaware corporation (the "Company"), proposes to
issue and sell to the underwriters named in Schedule II hereto (the
"Underwriters"), for whom you are acting as representatives (the
"Representatives"), __________ shares (the "Initial Shares") of the Company's
common stock, $0.001 par value (the "Common Stock"). Such Initial Shares are to
be sold to each Underwriter, acting severally and not jointly, in such amounts
as are listed in Schedule II opposite the name of each Underwriter. The Company
also grants to the Underwriters, severally and not jointly, the option described
in Section 2(c) to purchase up to _____ additional shares (the "Option Shares";
together with the Initial Shares, the "Shares") of Common Stock to cover
over-allotments. The Common Stock is described more fully in each Final
Prospectus, referred to below. If the firm or firms listed in Schedule II hereto
include only the firm or firms listed in Schedule I hereto, then the terms
"Underwriters" and "Representatives," as used herein, each shall be deemed to
refer to such firm or firms.
1. Representations and Warranties of the Company. The Company represents
and warrants to and agrees with each of the Underwriters that:
(a) The Company meets the requirements for use of Form S-3 under the
Securities Act of 1933, as amended (the "Act") and has filed with the Securities
and Exchange Commission (the "Commission") a registration statement on such form
(the file number of which is set forth in Schedule I hereto), which has become
effective, for the registration under the Act of the Shares. Such registration
statement, as amended as of the date of this Agreement, meets the requirements
set forth in Rule 415(a)(1) under the Act and complies in all other material
Such registration statement, including the exhibits thereto, as amended as of
the date of this Agreement, is hereinafter called the "Registration Statement";
such prospectus in the form in which it appears in the Registration Statement is
hereinafter called the "Basic Prospectus"; and such supplemented form of
prospectus, including any final prospectus in preliminary form, in the form in
which it shall be filed with the Commission pursuant to Rule 424 or Rule 434
(including the Basic Prospectus as so supplemented), is hereinafter called the
"Final Prospectus." Unless expressly otherwise provided herein, Any reference
herein to the Registration Statement, the Basic Prospectus or any Final
Prospectus shall be deemed to refer to and include the documents incorporated by
reference therein pursuant to Item 12 of Form S-3 which were filed under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), on or before
the date of this Agreement, or the issue date of the Basic Prospectus or any
Final Prospectus, as the case may be; and any reference herein to the terms
"amend," "amendment" or "supplement" with respect to the Registration Statement,
the Basic Prospectus or any Final Prospectus shall be deemed to refer to and
include the filing of any document under the Exchange Act after the date of this
Agreement, or the issue date of the Basic Prospectus or any Final Prospectus, as
the case may be, and deemed to be incorporated therein by reference.
(b) Each Final Prospectus, if filed by electronic transmission pursuant to
the Commission's Electronic Data Gathering, Analysis and Retrieval System
("XXXXX") (except as may be permitted by Regulation S-T under the Act), was
identical to the copy thereof delivered to the Underwriters for use in
connection with the offer and sale of the Shares. As of the date hereof, when
any Final Prospectus is first filed with the Commission pursuant to Rule 424(b)
or Rule 434 of the regulations under the Act, when any supplement to or
amendment of any Final Prospectus is filed with the Commission and at the
Closing Date (as defined below), the Registration Statement and each Final
Prospectus and any amendments thereof and supplements thereto complied (and, in
the event of any of the aforementioned filings that may occur in the future
will, at the time of such filing(s), comply) in all material respects with the
applicable provisions of the Act and the regulations thereunder, did not and
will not contain an untrue statement of a material fact and did not and will not
omit to state any material fact required to be stated therein or necessary in
order to make the statements therein not misleading. If Rule 434 is used, the
Company will comply with the requirements of Rule 434. The documents which are
incorporated by reference in any Final Prospectus or from which information is
so incorporated by reference, when they became effective or were filed with the
Commission, as the case may be, complied in all material respects with the
requirements of the Act and the rules and regulations thereunder or the Exchange
Act and the rules and regulations thereunder, as applicable, and did not, when
such documents were so filed, contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading, and any documents so filed and incorporated by
reference subsequent to the effective date of the Registration Statement shall,
when they are filed with the Commission, conform in all material respects with
the requirements of the Act and the rules and regulations thereunder and the
Exchange Act and the rules and regulations thereunder, as applicable. The
Commission has not issued any stop order suspending the effectiveness of the
Registration Statement or any order preventing or suspending the use of any
Final Prospectus or, to the knowledge of the Company, instituted proceedings for
that purpose.
(c) As of the date of this Agreement, the Company has, and at the time of
purchase will have, an authorized capitalization as set forth in the
Registration Statement and the Basic Prospectus; all of the issued and
outstanding shares of capital stock of the Company, including the Common Stock,
have been duly and validly authorized and issued and are fully paid and
non-assessable, have been issued in compliance with all applicable laws
(including, but not limited to, federal and state securities laws) and were not
issued in violation of any preemptive right, resale right, right of first
refusal or similar right.
-2-
(d) Except as disclosed in the Registration Statement, each of the Company
and each subsidiary of the Company set forth on Schedule III hereto (each a
"Subsidiary" and, collectively, the "Subsidiaries") has been duly incorporated
and is validly existing as a corporation and is in good standing under the laws
of its respective jurisdiction of incorporation with all requisite corporate
power and authority to own, lease and operate its respective properties and to
conduct its respective business as conducted and as proposed to be conducted as
described in the Registration Statement and Final Prospectus.
(e) Each of the Company and the Subsidiaries is duly qualified or
registered to do business as a foreign corporation in good standing in each
jurisdiction in which it conducts its respective business as conducted, and as
proposed to be conducted as described in the Registration Statement and Basic
Prospectus, where the ownership or leasing of its properties or the conduct of
its business requires such qualification, except where the failure to so
qualify, individually or in the aggregate, would not have a material adverse
effect on the business, prospects, properties, financial condition or results of
operation of the Company and the Subsidiaries, taken as a whole (a "Material
Adverse Effect").
(f) The Company has no significant subsidiaries (as defined in Rule 1-02 of
Regulation S-X under the Act) other than the Subsidiaries; other than the
Subsidiaries the Company does not own, directly or indirectly, any shares of
stock or any other equity or long-term debt securities of any corporation or
have any equity interest in any firm, partnership, joint venture, association or
other entity.
(g) Complete and correct copies of the certificates of incorporation and of
the bylaws of the Company and the Subsidiaries and all amendments thereto have
been delivered to you or included in the Registration Statement, and except as
set forth in the Registration Statement no changes therein will be made during
the term of this Agreement.
(h) Except as disclosed in the Registration Statement, all of the
outstanding shares of capital stock of each of the Subsidiaries have been duly
authorized and validly issued, are fully paid and non-assessable and (except as
otherwise described in this Section 3(h)) are owned by the Company subject to no
security interest, other encumbrance or adverse claims; no options, warrants or
other rights to purchase, agreements or other obligations to issue or other
rights to convert any obligation into shares of capital stock or ownership
interests in the Subsidiaries are outstanding.
(i) Except as disclosed in the Registration Statement, the Company and each
of the Subsidiaries are in compliance in all material respects with all
applicable laws, orders, rules, regulations, directives, decrees and judgments.
(j) Except as disclosed in the Registration Statement, neither the Company
nor any of the Subsidiaries is in breach of, or in default (nor has any event
occurred which with notice, lapse of time, or both would result in any breach
of, or constitute a default under), under (a) its respective certificate of
incorporation, charter or by-laws or (b) in the performance or observance of any
obligation, agreement, covenant or condition contained in any license,
indenture, mortgage, deed of trust, bank loan or credit agreement or other
evidence of indebtedness, or any lease, contract or other agreement or
instrument to which the Company or any of the Subsidiaries is a party or by
-3-
which any of them or any of their properties is bound, except in the case of
clause (b), for such breaches or defaults as would not reasonably be expected to
have a Material Adverse Effect.
(k) The execution, delivery and performance of this Agreement, the issuance
and sale of the Shares and the consummation of the transactions contemplated
hereby will not conflict with, or result in any breach of or constitute a
default under (nor constitute any event which with notice, lapse of time, or
both would result in any breach of, or constitute a default under) (i) any
provision of the articles of incorporation, charter or by-laws of the Company or
any of the Subsidiaries, or (ii) any provision of any license, indenture,
mortgage, deed of trust, bank loan or credit agreement or other evidence of
indebtedness, or any lease, contract or other agreement or instrument to which
the Company or any of the Subsidiaries is a party or by which any of them or
their respective properties may be bound or affected, or (iii) any federal,
state, local or foreign law, regulation or rule or any decree, judgment or order
applicable to the Company or any of the Subsidiaries, except in the case of
clause (ii) for such conflicts, breaches, or defaults, individually or in the
aggregate, as would not reasonably be expected to have a Material Adverse
Effect.
(l) The Company has full legal right, power and authority to enter into and
perform this Agreement and to consummate the transactions contemplated herein;
this Agreement has been duly authorized, executed and delivered by the Company
and is a legal, valid and binding agreement of the Company enforceable in
accordance with its terms, except (i) as may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors'
rights generally, or (ii) as any rights to indemnity or contribution hereunder
may be limited by federal and state securities laws and public policy
considerations.
(m) The capital stock of the Company, including the Shares, conforms in all
material respects to the description thereof contained in the Registration
Statement and Final Prospectus.
(n) The issuance and sale of the Shares to the Underwriters hereunder have
been duly authorized by the Company; when issued and delivered against payment
therefor as provided in this Agreement, the Shares will be validly issued, fully
paid and non-assessable and the issuance of the Shares will not be subject to
any preemptive or similar rights; except as disclosed in the Registration
Statement no person or entity holds a right to require or participate in the
registration under the Act of the Shares pursuant to the Registration Statement;
no person or entity has a right of participation or first refusal with respect
to the sale of the Shares by the Company.
(o) Except as disclosed in the Registration Statement, there are no
contracts, agreements or understandings between the Company or its Subsidiaries
and any person or entity granting such person or entity the right, contractual
or otherwise, to cause the Company to issue to it, or register pursuant to the
Act, any securities or shares of capital stock of the Company upon the issue and
sale of the Shares to the Underwriters hereunder, or to require the Company to
include such securities with the Shares registered pursuant to the Registration
Statement, nor does any person have preemptive rights, co-sale rights, rights of
-4-
first refusal or other rights to purchase any of the Shares other than those
that have been expressly waived before the date hereof.
(p) The form of certificates evidencing the Shares (to the extent such
Shares are certificated) complies with all applicable legal requirements and, in
all material respects, with all applicable requirements of the charter and
bylaws of the Company and the requirements of the NASD.
(q) No approval, authorization, consent or order of or filing with any
federal, state or local governmental or regulatory commission, board, body,
authority or agency is required in connection with (i) the execution, delivery
and performance by the Company of this Agreement and the consummation of the
transactions contemplated hereby or (ii) the sale and delivery of the Shares,
other than (x) such as have been obtained, or will have been obtained at the
time of purchase under the Act or the Exchange Act, (y) such approvals as have
been obtained in connection with the approval of the listing of the Shares on
the Nasdaq National Market System and (z) any necessary qualification under the
securities or blue sky laws of the various jurisdictions in which the Shares are
being offered by the Underwriters.
(r) Ernst & Young LLP, whose report on the consolidated financial
statements of the Company and the Subsidiaries is filed with the Commission as
part of the Registration Statement and Final Prospectus, are and were during the
periods covered by their reports independent public accountants as required by
the Act.
(s) Each of the Company and the Subsidiaries has all necessary licenses,
authorizations, consents and approvals and has made all necessary filings
required under any federal, state, local or foreign law, regulation or rule, and
has obtained all necessary authorizations, consents and approvals from other
persons, in order to conduct its respective business, unless the failure to
possess such licenses, authorizations, consents and other governmental or
regulatory authorizations and approvals, individually or in the aggregate, could
not reasonably be expected to have Material Adverse Effect; neither the Company
nor any of the Subsidiaries is in violation of, in default under or has received
any notice regarding a possible violation, default or revocation of any such
license, authorization, consent or approval or any federal, state, local or
foreign law, regulation or rule or any decree, order or judgment applicable to
the Company or any of the Subsidiaries the effect of which could reasonably be
expected to have a Material Adverse Effect.
(t) All legal or governmental proceedings, contracts, leases or documents
of a character required to be described in the Registration Statement or the
Prospectus or to be filed as an exhibit to the Registration Statement have been
so described or filed as required.
(u) Except as disclosed in the Registration Statement, there are no legal
or governmental proceedings pending or threatened to which the Company or any of
the Subsidiaries or any of their respective officers is a party or of which any
of their respective properties is subject at law or in equity, or before or by
any federal, state, local or foreign governmental or regulatory commission,
which, if determined adversely to the Company or any of its Subsidiaries, could
result in a judgment, decree or order which could reasonably be expected to have
-5-
a Material Adverse Effect or prevent consummation of the transactions
contemplated hereby.
(v) The consolidated financial statements of the Company and the
Subsidiaries included in the Registration Statement and the Final Prospectus
present fairly in all material respects the consolidated financial position of
the Company and the Subsidiaries as of the dates indicated and the consolidated
results of operations and cash flows of the Company and the Subsidiaries for the
periods specified; such financial statements have been prepared in conformity
with generally accepted accounting principles as applied in the United States
and on a consistent basis during the periods involved and in accordance with
Regulation S-X promulgated by the Commission; the financial statement schedules
included or incorporated by reference in the Registration Statement and the
Final Prospectus fairly present in all material respects the information
required to be shown therein; no other financial statements or schedules are
required by Form S-3 or otherwise to be included in the Registration Statement
or Final Prospectus; any pro forma financial statements and other pro forma
financial information included in the Registration Statement and the Final
Prospectus present fairly the information shown therein, have been prepared in
accordance with the Commission's rules and guidelines for pro forma financial
statements, have been properly compiled on the pro forma bases set forth therein
and, in the opinion of the Company, the assumptions used in the preparation
thereof are reasonable and the adjustments used therein are appropriate to
reflect the transaction or circumstances referred to therein.
(w) Subsequent to the respective dates as of which information is given in
the Registration Statement and the Final Prospectus, there has not been (i) any
material adverse change, or any development involving a prospective material
adverse change, in the business, prospects, properties or assets described or
referred to in the Registration Statement, or the results of operations,
condition (financial or otherwise), business or operations of the Company and
the Subsidiaries, whether or not arising in the ordinary course of business, or
(ii) any transaction which is material to the Company or the Subsidiaries,
planned or entered into by the Company or any of the Subsidiaries, or (iii) any
obligation, direct or contingent, which is material to the Company and the
Subsidiaries, incurred by the Company or the Subsidiaries, except obligations
incurred in the ordinary course of business, or (iv) any change in the capital
stock or outstanding indebtedness of the Company or the Subsidiaries, or (v) any
dividend or distribution of any kind declared, paid or made on the capital stock
of the Company. Neither the Company nor the Subsidiaries has any material
contingent obligation which is not disclosed in the Registration Statement.
(x) The Company has filed in a timely manner all reports required to be
filed pursuant to Sections 13, 14, 15(d) of the Exchange Act during the
preceding twelve calendar months and if during such period the Company has
relied on Rule 12b-25(b) under the Exchange Act ("Rule 12b-25(b)") with respect
to a report or a portion of a report, that report or portion of a report has
actually been filed within the time period prescribed by Rule 12b-25(b).
(y) The Company is not and, after giving effect to the offering and sale of
the Shares, will not be an "investment company" or an entity "controlled" by an
"investment company," as such terms are defined in the Investment Company Act of
1940, as amended (the "Investment Company Act").
-6-
(z) Except as disclosed in the Final Prospectus, there are no outstanding
(i) securities or obligations of the Company or any of its Subsidiaries
convertible into or exchangeable for any capital stock of the Company or any
such Subsidiary, or (ii) warrants, rights or options to subscribe for or
purchase from the Company or any such Subsidiary any such capital stock or any
such convertible or exchangeable securities or obligations, or (iii) obligations
of the Company or any such Subsidiary to issue any shares of capital stock, any
such convertible or exchangeable securities or obligation, or any such warrants,
rights or options.
(aa) Each of the Company, the Subsidiaries, and each of their respective
officers, directors and controlling persons has not taken, and will not take,
directly or indirectly, any action which is designed to or which has constituted
or which might reasonably be expected to cause or result in stabilization or
manipulation of the price of any security of the Company to facilitate the sale
or resale of the Shares.
(bb) The Company (i) is not required to register as a "broker" or "dealer"
in accordance with the provisions of the Exchange Act or the rules and
regulations thereunder, and (ii) directly, or indirectly through one or more
intermediaries, does not control any member firm of the NASD.
(cc) The Company has not relied upon the Underwriters or legal counsel for
the Underwriters for any legal, tax or accounting advice in connection with the
offering and sale of the Shares.
(dd) Any certificate signed by any officer of the Company or any Subsidiary
delivered to the Underwriters or to counsel for the Underwriters pursuant to or
in connection with this Agreement shall be deemed a representation and warranty
by the Company to the Underwriters as to the matters covered thereby.
(ee) To the Company's knowledge, all agreements between the Company or any
of the Subsidiaries and third parties expressly referenced in the Final
Prospectus are legal, valid and binding obligations of the Company or one or
more of the Subsidiaries, enforceable in accordance with their respective terms,
except to the extent enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors' rights generally
and by general principles of equity.
(ff) No relationship, direct or indirect, exists between or among the
Company or any of the Subsidiaries, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company or any of the
Subsidiaries, on the other hand, which is required by the Act to be described in
the Registration Statement and the Final Prospectus that is not so described.
(gg) With such exceptions as could not reasonably be expected to have a
Material Adverse Effect on the Company and the Subsidiaries, taken as a whole,
the Company and the Subsidiaries have good and marketable title in fee simple to
all real property, if any, and good title to all personal property owned by
them, in each case free and clear of all liens, security interests, pledges,
charges, encumbrances, mortgages and defects, except such as are disclosed in
-7-
the Final Prospectus or such as do not materially and adversely affect the value
of such property and do not interfere with the use made or proposed to be made
of such property by the Company and the Subsidiaries; and any real property and
buildings held under lease by the Company or any Subsidiary are held under
valid, existing and enforceable leases, with such exceptions as are disclosed in
the Final Prospectus or are not material and do not interfere with the use made
or proposed to be made of such property and buildings by the Company or such
Subsidiary.
(hh) The Company and the Subsidiaries have ownership or license or legal
right to use all material patent, copyright, trade secret and trademark rights
known by it to be necessary to the conduct of the business of the Company and
the Subsidiaries as now conducted (collectively, "Intellectual Property") other
than Intellectual Property generally available on commercial terms from other
sources.
(ii) All material licenses or other material agreements under which (i) the
Company and the Subsidiaries are granted rights in Intellectual Property, other
than Intellectual Property generally available on commercial terms from other
sources, and (ii) the Company or any Subsidiary has granted rights to others in
Intellectual Property owned or licensed by the Company or the Subsidiaries, are
in full force and effect and there is no material default by the Company or any
Subsidiary or, to the Company's knowledge, any other party thereto.
(jj) Each of the Company and the Subsidiaries have taken all reasonable
steps required in accordance with sound business practice and business judgment
to establish and preserve its ownership of all material copyright, trade secret
and other proprietary rights with respect to its products and technology.
(kk) To the Company's knowledge, after due inquiry, the present business,
activities and products of the Company and the Subsidiaries do not infringe any
Intellectual Property of any other person, except where such infringement would
not, individually or in the aggregate, have a Material Adverse Effect on the
Company. Except as described in documents filed with the Commission, to the
Company's knowledge, no proceeding charging the Company or any Subsidiary with
infringement of any adversely held Intellectual Property has been filed; the
Company and the Subsidiaries are not making unauthorized use of any confidential
information or trade secrets obtained by the Company or its Subsidiaries from
any other person; the activities of each of the Company or the Subsidiaries or
any of its employees on behalf of the Company or any Subsidiary do not violate
any agreements or arrangements known to the Company or any Subsidiary which any
such employees have with other persons, if any.
(ll) The Company and each of its Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that (i)
transactions are executed in accordance with management's general or specific
authorizations; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted
accounting principles as applied in the United States and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with
management's general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.
-8-
(mm) Each of the Company and the Subsidiaries have filed on a timely basis
all material federal, state, local and foreign income and franchise tax returns
required to be filed through the date hereof and have paid all taxes shown as
due thereon; and no tax deficiency has been asserted against any such entity,
nor does any such entity know of any tax deficiency which is likely to be
asserted against any such entity which if, determined adversely to any such
entity, could have a Material Adverse Effect; all tax liabilities are adequately
provided for on the respective books of such entities.
(nn) Neither the Company nor any of the Subsidiaries nor, to the best of
the Company's knowledge, any agent, officer or director purporting to act on
behalf of the Company or any of the Subsidiaries has at any time; (i) made any
contributions to any candidate for political office, or failed to disclose fully
any such contributions, in violation of law, or (ii) made any payment to any
state, federal or foreign governmental officer or official, or other person
charged with similar public or quasi-public duties, other than payments required
or allowed by applicable law, or (iii) received or retained any funds in
violation of law or of a character required to be disclosed in the Final
Prospectus.
(oo) In connection with this offering, the Company has not offered and will
not offer shares of its Common Stock or any other securities convertible into or
exchangeable or exercisable for shares of Common Stock in a manner in violation
of the Act; the Company has not distributed and will not distribute any offering
material in connection with the offer and sale of the Shares, other than the
Final Prospectus, Registration Statement and other materials permitted by the
Act.
2. Purchase and Sale.
(a) Subject to the terms and conditions and in reliance upon the
representations and warranties herein set forth, the Company agrees to sell to
each Underwriter, and each Underwriter agrees, severally and not jointly, to
purchase from the Company the respective number of Initial Shares set forth
opposite such Underwriter's name in Schedule II hereto, except that, if Schedule
I hereto provides for the sale of Initial Shares pursuant to delayed delivery
arrangements, the respective amounts of Initial Shares to be purchased by the
Underwriters shall be set forth in Schedule II hereto, less the respective
amounts of Contract Securities determined as provided below. Shares to be
purchased by the Underwriters are herein sometimes called the "Underwriters'
Securities" and Shares to be purchased pursuant to Delayed Delivery Contracts as
hereinafter provided are herein called "Contract Securities."
If so provided in Schedule I hereto, the Underwriters are authorized to
solicit offers to purchase Initial Shares from the Company pursuant to delayed
delivery contracts ("Delayed Delivery Contracts"), substantially in the form of
Schedule IV hereto but with such changes therein as the Company may authorize or
approve. The Underwriters will endeavor to make such arrangements and, as
compensation therefor, the Company will pay to the Representatives, for the
account of the Underwriters, on the Closing Date (as defined below), the
purchase price set forth on Schedule I hereto, of the Initial Shares for which
Delayed Delivery Contracts are made. Delayed Delivery Contracts are to be with
institutional investors, including commercial and savings banks, insurance
-9-
companies, pension funds, investment companies and educational and charitable
institutions. The Company will make Delayed Delivery Contracts in all cases
where sales of Contract Securities arranged by the Underwriters have been
approved by the Company but, except as the Company may otherwise agree, each
such Delayed Delivery Contract must be for not less than the minimum amount of
Initial Shares set forth in Schedule I hereto and the aggregate amount of
Contract Securities may not exceed the maximum aggregate amount set forth in
Schedule I hereto. The Underwriters will not have any responsibility in respect
of the validity or performance of Delayed Delivery Contracts. The amount of
Initial Shares to be purchased by each Underwriter as set forth in Schedule II
hereto shall be reduced by an amount which shall bear the same proportion to the
total amount of Contract Securities as the amount of Initial Shares set forth
opposite the name of such Underwriter bears to the aggregate amount set forth in
Schedule II hereto, except to the extent that you determine that such reduction
shall be otherwise than in such proportion and so advise the Company in writing;
provided, however, that the total amount of Initial Shares to be purchased by
all Underwriters shall be the aggregate amount set forth in Schedule II hereto,
less the aggregate amount of Contract Securities.
(b) The initial public offering price and the purchase price of the Initial
Shares shall be set forth in a separate written instrument (the "Pricing
Agreement") signed by the Representatives and the Company, the form of which is
attached hereto as Schedule V. From and after the execution and delivery of the
Pricing Agreement, this Agreement shall be deemed to include the Pricing
Agreement. The purchase price per share to be paid by the several Underwriters
for the Initial Shares shall be an amount equal to the initial public offering
price, less an amount per share to be determined by agreement among the
Representatives and the Company.
(c) In addition, on the basis of the representations and warranties
contained herein, and subject to the terms and conditions set forth herein, the
Company grants an option to the Underwriters, severally and not jointly, to
purchase up to an additional _______ Option Shares at the same price per share
determined as provided above for the Initial Shares. The option hereby granted
will expire 30 days after the date of the Pricing Agreement, and may be
exercised, in whole or in part (but not more than once by written notice) only
for the purpose of covering over-allotments upon notice by the Representatives
to the Company setting forth the number of Option Shares as to which the several
Underwriters are exercising the option, and the time and date of payment and
delivery thereof. Such time and date of delivery (the "Date of Delivery") shall
be determined by the Representatives but shall not be later than seven full
business days after the exercise of such option and not in any event prior to
the Closing Date (as defined below). If the option is exercised as to all or any
portion of the Option Shares, the Option Shares as to which the option is
exercised shall be purchased by the Underwriters severally and not jointly, in
proportion to, as nearly as practicable, their respective Initial Shares
underwriting obligations as set forth on Schedule II.
3. Delivery and Payment. Delivery of and payment for the Initial Shares
shall be made on the date and at the time specified in the Pricing Agreement,
which date and time may be postponed by agreement between the Representatives
and the Company (such date and time of delivery and payment for the Initial
Shares being herein called the "Closing Date"). Delivery of the Initial Shares
shall be made to the Representatives for the respective accounts of the several
Underwriters against payment by the several Underwriters through the
Representatives of the purchase price thereof in the manner set forth in
Schedule I hereto. Unless otherwise agreed, certificates for the Initial Shares
-10-
shall be in the form set forth in Schedule I hereto, and such certificates may
be deposited with The Depository Trust Company ("DTC") or a custodian for DTC
and registered in the name of Cede & Co., as nominee for DTC.
In addition, in the event that any or all of the Option Shares are
purchased by the Underwriters, delivery and payment for the Option Shares shall
be made at the office specified for delivery of the Initial Shares in the
Pricing Agreement, or at such other place as the Company and the Representatives
shall determine, on the Date of Delivery as specified in the notice from the
Representatives to the Company. Delivery of the Option Shares shall be made to
the Representatives against payment by the Underwriters through the
Representatives of the purchase price thereof to or upon the order of the
Company in the manner set forth in Schedule I hereto. Unless otherwise agreed,
certificates for the Option Shares shall be in the form set forth in Schedule I
hereto, and such certificates shall be registered in such names and in such
denominations as the Representatives may request not less than three full
business days in advance of the Date of Delivery.
4. Agreements. The Company agrees with the several Underwriters that:
(a) Prior to the termination of the offering of the Shares, the Company
will not file any amendment of the Registration Statement or supplement
(including any Final Prospectus) to the Basic Prospectus unless the Company has
furnished you a copy for your review prior to filing and will not file any such
proposed amendment or supplement to which you reasonably object. Subject to the
foregoing sentence, the Company will cause each Final Prospectus to be filed
with the Commission pursuant to Rule 424 or Rule 434 via XXXXX. The Company will
advise the Representatives promptly (i) when each Final Prospectus shall have
been filed with the Commission pursuant to Rule 424 or Rule 434, (ii) when any
amendment to the Registration Statement relating to the Shares shall have become
effective, (iii) of any request by the Commission for any amendment of the
Registration Statement or amendment of or supplement to the Final Prospectus or
for any additional information, (iv) of the issuance by the Commission of any
stop order suspending the effectiveness of the Registration Statement or the
institution or threatening of any proceeding for that purpose and (v) of the
receipt by the Company of any notification with respect to the suspension of the
qualification of the Shares for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose. The Company will use its
reasonable best efforts to prevent the issuance of any such stop order and, if
issued, to obtain as soon as possible the withdrawal thereof.
(b) If, at any time when a prospectus relating to the Shares is required to
be delivered under the Act, except with respect to any such delivery requirement
imposed upon an affiliate of the Company in connection with any secondary market
sales, any event occurs as a result of which each Final Prospectus as then
amended or supplemented would include any untrue statement of a material fact or
omit to state any material fact necessary to make the statements therein in
light of the circumstances under which they were made not misleading, or if it
shall be necessary to amend or supplement the Final Prospectus to comply with
the Act or the Exchange Act or the respective rules thereunder, the Company
promptly will prepare and file with the Commission, subject to the first
sentence of paragraph (a) of this Section 4, an amendment or supplement which
will correct such statement or omission or an amendment which will effect such
compliance.
-11-
(c) The Company will make generally available to its security holders and
to the Representatives as soon as practicable, but not later than 90 days after
the close of the period covered thereby, an earnings statement (in form
complying with the provisions of Rule 158 under the Act) covering a twelve month
period beginning not later than the first day of the Company's fiscal quarter
next following the "effective date" (as defined in said Rule 158) of the
Registration Statement.
(d) The Company will furnish to the Representatives and counsel for the
Underwriters, without charge, copies of the Registration Statement (including
exhibits thereto) and each amendment thereto which shall become effective on or
prior to the Closing Date and, so long as delivery of a prospectus by an
Underwriter or dealer may be required by the Act, as many copies of any Final
Prospectus and any amendments thereof and supplements thereto as the
Representatives may reasonably request. The Company will pay the expenses of
printing all documents relating to the offering.
(e) The Company will arrange for the qualification of the Shares for sale
under the laws of such jurisdictions as the Representatives may reasonably
designate, will maintain such qualifications in effect so long as required for
the distribution of the Shares; provided, however, that the Company shall not be
required to (i) qualify to do business in any jurisdiction where it is not now
so qualified, (ii) take any action which would subject it to general or
unlimited service of process of any jurisdiction where it is not now so subject,
(iii) become a dealer of securities or (iv) become subject to taxation in any
jurisdiction where it is not now so subject.
(f) Until the business day following the Closing Date, the Company will
not, without the consent of the Representatives, offer or sell, or announce the
offering of, any securities covered by the Registration Statement or by any
other registration statement filed under the Act; provided, however, the Company
may, at any time, offer or sell or announce the offering of any securities (A)
covered by a registration statement on Form S-8 or (B) covered by a registration
statement on Form S-3 and pursuant to which the Company issues securities for
its dividend reinvestment plan.
(g) The Company will prepare a prospectus supplement with respect to any
Shares sold by the Company pursuant to this Agreement, in a form previously
approved by the Underwriters, and to file such prospectus supplement pursuant to
Rule 424(b) under the Act not later than 5:00 p.m. on the second business day
after the signing of this Agreement, and to provide copies of such prospectus
supplement to the Underwriters via e-mail in ".pdf" format to an account
designated by the Underwriters.
(h) The Company will make available to the Underwriters, as soon as
practicable after the Registration Statement becomes effective, and thereafter
from time to time to furnish to the Underwriters, as many copies of the Final
Prospectus (or of the Final Prospectus as amended or supplemented if the Company
shall have made any amendments or supplements thereto after the effective date
of the Registration Statement) as the Underwriters may reasonably request for
the purposes contemplated by the Act; and for so long as this Agreement is in
effect, or in any case if any Underwriter is required to deliver a prospectus
within the nine-month period referred to in Section 10(a)(3) of the Act in
connection with the sale of the Shares, the Company will prepare and file
-12-
promptly such amendment or amendments to the Registration Statement and the
Final Prospectus as may be necessary to comply with the requirements of Section
10(a)(3) of the Act.
(i) The Company will furnish to you for a period of one year from the date
of this Agreement (i) copies of any reports or other communications which the
Company shall send to its stockholders or shall from time to time publish or
publicly disseminate, (ii) copies of all annual, quarterly and current reports
filed with the Commission on Forms 10-K, 10-Q and 8-K, or such other similar
form as may be designated by the Commission, and (iii) copies of documents or
reports filed with any national securities exchange on which any class of
securities of the Company is listed, and to furnish to you from time to time
during the term of this Agreement such other information as you may reasonably
request regarding the Company or the Subsidiaries, in each case as soon as such
reports, communications, documents or information becomes available.
(j) The Company will furnish to you four signed copies of the Registration
Statement, as initially filed with the Commission, and of all amendments
thereto, including all exhibits thereto and all documents incorporated by
reference therein.
(k) The Company will furnish to you upon request as early as practicable
prior to the time of purchase a copy of the latest available unaudited interim
consolidated financial statements, if any, of the Company and its Subsidiaries
which have been read by the Company's independent certified public accountants,
as stated in their letter to be furnished pursuant to Section 6 hereof.
(l) The Company will apply the net proceeds from the sale of the Shares in
the manner set forth under the caption "Use of Proceeds" in the Final
Prospectus.
(m) The Company will pay all costs, expenses, fees and taxes in connection
with (i) the preparation and filing of the Registration Statement, each Basic
Prospectus, the Final Prospectus, and any amendments or supplements thereto, and
the printing and furnishing of copies of each thereof to the Underwriters and to
dealers (including costs of mailing and shipment), (ii) the registration, issue,
sale and delivery of the Shares, (iii) the producing, word processing and/or
printing of this Agreement, any powers of Attorney and any closing documents
(including compilations thereof) and the reproduction and/or printing and
furnishing of copies of each thereof to the Underwriters (including costs of
mailing and shipment), (iv) the qualification of the Shares for offering and
sale under state laws and the determination of their eligibility for investment
under state law as aforesaid (including the legal fees and filing fees and other
disbursements of counsel for the Underwriters) and the printing and furnishing
of copies of any blue sky surveys or legal investment surveys to the
Underwriters, (v) the listing of the Shares on the Nasdaq National Market System
(the "Exchange") and any registration thereof under the Exchange Act, (vi) any
filing for review of the public offering of the Shares by the NASD, including
the fees and disbursements of counsel to the Underwriters in connection
therewith, (vii) all other fees and disbursements of counsel to the Company, and
(viii) the performance of the Company's other obligations hereunder; provided
that the Underwriters shall be responsible for any transfer taxes on resale of
Shares by them.
-13-
(n) The Company will furnish to you, before filing with the Commission
subsequent to the effective date of the Registration Statement and during the
period referred to in paragraph (i) above, a copy of any document proposed to be
filed pursuant to Section 13, 14 or 15(d) of the Exchange Act.
5. Reimbursement of Underwriters' Expenses. If the Shares are not delivered
for any reason other than the termination of this Agreement pursuant to the
first two paragraphs of Section 8 hereof or the default by one or more of the
Underwriters in its or their respective obligations hereunder, the Company
shall, in addition to paying the amounts described in Section 4(m) hereof,
reimburse the Underwriters for all of their reasonable out-of-pocket expenses,
including the fees and disbursements of their counsel. If this agreement is
terminated pursuant to Section 9 hereof by reason of the default of one or more
Underwriters, the Company shall not be obligated to reimburse any defaulting
Underwriter on account of those expenses.
6. Conditions to the Obligations of the Underwriters. The obligations of
the Underwriters to purchase the Shares shall be subject to the accuracy of the
representations and warranties on the part of the Company contained herein as of
the date hereof, as of the date of the effectiveness of any amendment to the
Registration Statement filed prior to the Closing Date (including the filing of
any document incorporated by reference therein) and as of the Closing Date, to
the accuracy of the statements of the Company made in any certificates pursuant
to the provisions hereof, to the performance by the Company of its obligations
hereunder and to the following additional conditions:
(a) No stop order suspending the effectiveness of the Registration
Statement, as amended from time to time, shall have been issued and no
proceedings for that purpose shall have been instituted or threatened; and any
Final Prospectus shall have been filed or mailed for filing with the Commission
within the time period prescribed by the Commission.
(b) The Company shall have furnished to the Representatives the opinion of
White & Case LLP, counsel for the Company, dated the Closing Date substantially
in the form attached hereto as Exhibit A.
(c) The Company shall have furnished to the Representatives the opinion of
White & Case LLP, counsel for the Company, dated the Closing Date, as to certain
intellectual property matters.
(d) The Representatives shall have received from counsel for the
Underwriters, such opinion or opinions, dated the Closing Date, with respect to
the issuance and sale of the Initial Shares, any Delayed Delivery Contracts, the
Registration Statement, the Final Prospectus and other related matters as the
Representatives may reasonably require, and the Company shall have furnished to
such counsel such documents as they request for the purpose of enabling them to
pass upon such matters.
(e) The Company shall have furnished to the Representatives a certificate
of the Company, signed by the President and Chief Executive Officer or a Senior
Vice President and the principal financial or accounting officer of the Company,
-14-
dated the Closing Date, to the effect that the signers of such certificate have
carefully examined the Registration Statement, the Final Prospectus and this
Agreement and that to the best of their knowledge:
(i) the representations and warranties of the Company in this Agreement are
true and correct in all material respects on and as of the Closing Date with the
same effect as if made on the Closing Date and the Company has complied with all
the agreements and satisfied all the conditions on its part to be performed or
satisfied at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness of the Registration
Statement, as amended, has been issued and no proceedings for that purpose have
been instituted or threatened; and
(iii) since the date of the most recent financial statements included in
the Final Prospectus, there has been no material adverse change in the condition
(financial or other), earnings, business or properties of the Company and its
Subsidiaries, whether or not arising from transactions in the ordinary course of
business, except as set forth in or contemplated in the Final Prospectus.
(f) At the Closing Date, Ernst & Young LLP shall have furnished to the
Representatives a letter or letters (which may refer to letters previously
delivered to one or more of the Representatives), dated as of the Closing Date,
in form and substance satisfactory to the Representatives.
(g) Subsequent to the respective dates as of which information is given in
the Registration Statement and the Final Prospectus, there shall not have been
(i) any change or decrease specified in the letter or letters referred to in
paragraph (f) of this Section 6 or (ii) any change, or any development involving
a prospective change, in or affecting the earnings, business or properties of
the Company and its subsidiaries the effect of which, in any case referred to in
clause (i) or (ii) above, is, in the reasonable judgment of the Representatives,
so material and adverse as to make it impractical or inadvisable to proceed with
the offering or the delivery of the Shares as contemplated by the Registration
Statement and the Final Prospectus.
(h) Prior to the Closing Date, the Company shall have furnished to the
Representatives such further information, certificates and documents as the
Representatives may reasonably request.
(i) The Company shall have accepted Delayed Delivery Contracts in any case
where sales of Contract Securities arranged by the Underwriters have been
approved by the Company.
If any of the conditions specified in this Section 6 shall not have been
fulfilled in all material respects when and as provided in this Agreement, or if
any of the opinions and certificates mentioned above or elsewhere in this
Agreement shall not be in all material respects reasonably satisfactory in form
and substance to the Representatives and their counsel, this Agreement and all
obligations of the Underwriters hereunder may be canceled at, or at any time
prior to, the Closing Date by the Representatives. Notice of such cancellation
shall be given to the Company in writing or by telephone or telegraph confirmed
in writing.
-15-
7. Conditions to Purchase of Option Shares. In the event the Underwriters
exercise the option granted in Section 2(c) hereof to purchase all or any
portion of the Option Shares and the Date of Delivery determined by the
Representatives pursuant to Section 2 is later than the Closing Date, the
obligations of the several Underwriters to purchase and pay for the Option
Shares that they shall have respectively agreed to purchase hereunder are
subject to the accuracy of the representations and warranties of the Company
contained herein, to the performance by the Company of its obligations hereunder
and to the following additional conditions:
(a) No stop order suspending the effectiveness of the Registration
Statement, as amended from time to time, shall have been issued and no
proceedings for that purpose shall have been instituted or threatened; and any
required filing of the Final Prospectus pursuant to Rule 424(b) or Rule 434
under the Act shall have been made within the proper time period.
(b) At the Date of Delivery, the Representatives shall have received, each
dated the Date of Delivery and relating to the Option Shares:
(i) the favorable opinion of White & Case LLP, counsel for the Company, in
form and substance satisfactory to counsel for the Underwriters, to the same
effect as the opinion required by Section 6(b);
(ii) the favorable opinion of White & Case LLP, counsel for the Company, in
form and substance satisfactory to counsel for the Underwriters, to the same
effect as the opinion required by Section 6(c);
(iii) the favorable opinion of counsel for the Underwriters, to the same
effect as the opinion required by Section 6(d);
(iv) a certificate, of President and Chief Executive Officer or Senior Vice
President of the Company and of the principal financial or accounting officer of
the Company with respect to the matters set forth in Section 6(e);
(v) a letter from Ernst & Young LLP, in form and substance satisfactory to
the Underwriters, substantially the same in scope and substance as the letter
furnished to the Underwriters pursuant to Section 6(f) except that the
"specified date" in the letter furnished pursuant to this Section 7(b)(v) shall
be a date not more than five days prior to the Date of Delivery;
(vi) Subsequent to the respective dates as of which information is given in
the Registration Statement and the Final Prospectus, there shall not have been
(i) any change or decrease specified in the letter or letters referred to in
paragraph (b)(v) of this Section 7 or (ii) any change, or any development
involving a prospective change, in or affecting the earnings, business or
properties of the Company and its subsidiaries the effect of which, in any case
referred to in clause (i) or (ii) above, is, in the judgment of the
Representatives, so material and adverse as to make it impractical or
inadvisable to proceed with the offering or the delivery of the Shares as
contemplated by the Registration Statement and the Final Prospectus; and
(vii) such other information, certificates and documents as the
Representatives may reasonably request.
-16-
If any of the conditions specified in this Section 7 shall not have been
fulfilled in all material respects when and as provided in this Agreement, or if
any of the opinions and certificates mentioned above or elsewhere in this
Agreement shall not be in all material respects reasonably satisfactory in form
and substance to the Representatives and their counsel, this Agreement and all
obligations of the Underwriters hereunder may be canceled at, or at any time
prior to, the Date of Delivery by the Representatives. Notice of such
cancellation shall be given to the Company in writing or by telephone or
facsimile confirmed in writing.
8. Effective Date of Agreement; Termination. This Agreement shall become
effective (i) if Rule 430A under the Act is not used, when you shall have
received notification of the effectiveness of the Registration Statement, or
(ii) if Rule 430A under the Act is used, when the parties hereto have executed
and delivered this Agreement.
The obligations of the several Underwriters hereunder shall be subject to
termination in the absolute discretion of you or any group of Underwriters
(which may include you) which has agreed to purchase in the aggregate at least
50% of the Shares, if, since the time of execution of this Agreement or the
respective dates as of which information is given in the Registration Statement
and Final Prospectus, (y) there has been any material adverse and unfavorable
change, financial or otherwise (other than as referred to in the Registration
Statement and Final Prospectus at the time of execution of this Agreement), in
the operations, business, condition or prospects of the Company and its
Subsidiaries taken as a whole, which would, in your judgment or in the judgment
of such group of Underwriters, make it impracticable to market the Shares, or
(z) there shall have occurred any downgrading, or any notice shall have been
given of (i) any intended or potential downgrading or (ii) any review or
possible change that does not indicate an improvement, in the rating accorded
any securities of or guaranteed by the Company or any Subsidiary by any
"nationally recognized statistical rating organization", as that term is defined
in Rule 436(g)(2) under the Act or, if, at any time prior to the time of
purchase trading in securities on the New York Stock Exchange, the American
Stock Exchange or the Nasdaq National Market shall have been suspended or
limitations or minimum prices shall have been established on the New York Stock
Exchange, the American Stock Exchange or the Nasdaq National Market, or if a
banking moratorium shall have been declared either by the United States or New
York State authorities, or if the United States shall have declared war in
accordance with its constitutional processes or there shall have occurred any
material outbreak or escalation of hostilities or other national or
international calamity or crisis of such magnitude in its effect on the
financial markets of the United States as, in your judgment or in the judgment
of such group of Underwriters, to make it impracticable to market the Shares.
If you or any group of Underwriters elects to terminate this Agreement as
provided in this Section 8, the Company and each other Underwriter shall be
notified promptly by letter or telegram.
If the sale to the Underwriters of the Shares, as contemplated by this
Agreement, is not carried out by the Underwriters for any reason permitted under
this Agreement or if such sale is not carried out because the Company shall be
unable to comply with any of the terms of this Agreement, the Company shall not
be under any obligation or liability under this Agreement (except to the extent
-17-
provided in Sections 4(m), 5 and 9 hereof), and the Underwriters shall be under
no obligation or liability to the Company under this Agreement (except to the
extent provided in Section 9 hereof) or to one another hereunder.
9. Increase in Underwriters' Commitments. Subject to Sections 6, 7 and 8,
if any Underwriter shall default in its obligation to take up and pay for the
Shares to be purchased by it hereunder (otherwise than for a reason sufficient
to justify the termination of this Agreement under the provisions of Section 8
hereof) and if the number of Shares which all Underwriters so defaulting shall
have agreed but failed to take up and pay for does not exceed 10% of the total
number of Shares, the non-defaulting Underwriters shall take up and pay for (in
addition to the aggregate number of Shares they are obligated to purchase
pursuant to Section 2 hereof) the number of Shares agreed to be purchased by all
such defaulting Underwriters, as hereinafter provided. Such Shares shall be
taken up and paid for by such non-defaulting Underwriter or Underwriters in such
amount or amounts as you may designate with the consent of each Underwriter so
designated or, in the event no such designation is made, such Shares shall be
taken up and paid for by all non-defaulting Underwriters pro rata in proportion
to the aggregate number of Shares set opposite the names of such non-defaulting
Underwriters in Schedule I.
Without relieving any defaulting Underwriter from its obligations
hereunder, the Company agrees with the non-defaulting Underwriters that it will
not sell any Shares hereunder unless all of the Shares are purchased by the
Underwriters (or by substituted Underwriters selected by you with the approval
of the Company or selected by the Company with your approval).
If a new Underwriter or Underwriters are substituted by the Underwriters or
by the Company for a defaulting Underwriter or Underwriters in accordance with
the foregoing provision, the Company or you shall have the right to postpone the
time of purchase for a period not exceeding five business days in order that any
necessary changes in the Registration Statement and Prospectus and other
documents may be effected.
The term "Underwriter" as used in this Agreement shall refer to and include
any Underwriter substituted under this Section 9 with like effect as if such
substituted Underwriter had originally been named in Schedule I.
If the aggregate number of Shares which the defaulting Underwriter or
Underwriters agreed to purchase exceeds 10% of the total number of Shares which
all Underwriters agreed to purchase hereunder, and if neither the non-defaulting
Underwriters nor the Company shall make arrangements within the five business
day period stated above for the purchase of all the Shares which the defaulting
Underwriter or Underwriters agreed to purchase hereunder, this Agreement shall
be terminated without further act or deed and without any liability on the part
of the Company to any non-defaulting Underwriter and without any liability on
the part of any non-defaulting Underwriter to the Company. Nothing in this
paragraph, and no action taken hereunder, shall relieve any defaulting
Underwriter from liability in respect of any default of such Underwriter under
this Agreement.
10. Indemnity and Contribution.
-18-
(a) The Company agrees to indemnify, defend and hold harmless each
Underwriter, its partners, directors and officers, and any person who controls
any Underwriter within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act, and the successors and assigns of all of the foregoing persons
from and against any loss, damage, expense, liability or claim (including the
reasonable cost of investigation) which, jointly or severally, any such
Underwriter or any such person may incur under the Act, the Exchange Act, the
common law or otherwise, insofar as such loss, damage, expense, liability or
claim arises out of or is based upon any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement (or in the
Registration Statement as amended by any post-effective amendment thereof by the
Company) or in a Prospectus (the term "Prospectus" for the purpose of this
Section 10 being deemed to include the Basic Prospectus and the Final Prospectus
as amended or supplemented by the Company), or arises out of or is based upon
any omission or alleged omission to state a material fact required to be stated
in either such Registration Statement or Prospectus or necessary to make the
statements made therein not misleading, except (i) insofar as any such loss,
damage, expense, liability or claim arises out of or is based upon any untrue
statement or alleged untrue statement of a material fact contained in and in
conformity with information furnished in writing by or on behalf of any
Underwriter through you to the Company expressly for use with reference to such
Underwriter in such Registration Statement or such Prospectus or arises out of
or is based upon any omission or alleged omission to state a material fact in
connection with such information required to be stated in such Registration
Statement or such Prospectus or necessary to make such information not
misleading, or (ii) with respect to any untrue statement or omission of material
fact made in the Prospectus, the indemnity agreement contained in this section
shall not inure to the benefit of any Underwriter from or through whom the
person asserting any such loss, claim, damage, liability or action purchased the
securities concerned, to the extent that any such loss, claim, damage, liability
or action of such Underwriter occurs under the circumstance where it shall have
been determined by a court of competent jurisdiction that (w) the Company had
previously furnished copies of the Prospectus, as amended or supplemented to the
Underwriter, (x) delivery of the Prospectus, as amended or supplemented, was
required by the Securities Act to be made to such person, (v) the untrue
statement or omission of a material fact contained in the Prospectus was
corrected in the Prospectus as amended or supplemented, and (z) there was not
sent or given to such person, at or prior to the written confirmation of the
sale of such securities to such person, a copy of the Prospectus as amended or
supplemented.
If any action, suit or proceeding (together, a "Proceeding") is brought
against an Underwriter or any such person in respect of which indemnity may be
sought against the Company pursuant to the foregoing paragraph, such Underwriter
or such person shall promptly notify the Company in writing of the institution
of such Proceeding and the Company shall assume the defense of such Proceeding,
including the employment of counsel reasonably satisfactory to such indemnified
party and payment of all reasonable fees and expenses; provided, however, that
the omission to so notify the Company shall not relieve the Company from any
liability which the Company may have to any Underwriter or any such person or
otherwise. Such Underwriter or such person shall have the right to employ its or
their own counsel in any such case, but the fees and expenses of such counsel
shall be at the expense of such Underwriter or of such person unless the
employment of such counsel shall have been authorized in writing by the Company
-19-
in connection with the defense of such Proceeding or the Company shall not have,
within a reasonable period of time in light of the circumstances, employed
counsel to have charge of the defense of such Proceeding or such indemnified
party or parties shall have reasonably concluded based on advice of counsel that
there may be defenses available to it or them which are different from,
additional to or in conflict with those available to the Company (in which case
the Company shall not have the right to direct the defense of such Proceeding on
behalf of the indemnified party or parties), in any of which events such
reasonable fees and expenses shall be borne by the Company and paid as incurred
(it being understood, however, that the Company shall not be liable for the
reasonable expenses of more than one separate counsel (in addition to any local
counsel) in any one Proceeding or series of related Proceedings in the same
jurisdiction representing the indemnified parties who are parties to such
Proceeding). The Company shall not be liable for any settlement of any
Proceeding effected without its written consent but if settled with the written
consent of the Company, the Company agrees to indemnify and hold harmless any
Underwriter and any such person from and against any loss or liability by reason
of such settlement. Notwithstanding the foregoing sentence, if at any time an
indemnified party shall have requested an indemnifying party to reimburse the
indemnified party for fees and expenses of counsel as contemplated by the second
sentence of this paragraph, then the indemnifying party agrees that it shall be
liable for any settlement of any Proceeding effected without its written consent
if (i) such settlement is entered into more than 60 business days after receipt
by such indemnifying party of the aforesaid request, (ii) such indemnifying
party shall not have reimbursed the indemnified party in accordance with such
request prior to the date of such settlement and (iii) such indemnified party
shall have given the indemnifying party at least 30 days' prior notice of its
intention to settle. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement of any pending or
threatened Proceeding in respect of which any indemnified party is or could have
been a party and indemnity could have been sought hereunder by such indemnified
party, unless such settlement includes an unconditional release of such
indemnified party from all liability on claims that are the subject matter of
such Proceeding and does not include an admission of fault, culpability or a
failure to act, by or on behalf of such indemnified party.
(b) Each Underwriter severally agrees to indemnify, defend and hold
harmless the Company, its directors and officers, and any person who controls
the Company within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act, and the successors and assigns of all of the foregoing persons
from and against any loss, damage, expense, liability or claim (including the
reasonable cost of investigation) which, jointly or severally, the Company or
any such person may incur under the Act, the Exchange Act, the common law or
otherwise, insofar as such loss, damage, expense, liability or claim arises out
of or is based upon any untrue statement or alleged untrue statement of a
material fact contained in and in conformity with information furnished in
writing by or on behalf of such Underwriter through you to the Company expressly
for use with reference to such Underwriter in the Registration Statement (or in
the Registration Statement as amended by any post-effective amendment thereof by
the Company) or in a Prospectus, or arises out of or is based upon any omission
or alleged omission to state a material fact in connection with such information
required to be stated in such Registration Statement or such Prospectus or
necessary to make such information not misleading.
If any Proceeding is brought against the Company or any such person in
respect of which indemnity may be sought against any Underwriter pursuant to the
foregoing paragraph, the Company or such person shall promptly notify such
-20-
Underwriter in writing of the institution of such Proceeding and such
Underwriter shall assume the defense of such Proceeding, including the
employment of counsel reasonably satisfactory to such indemnified party and
payment of all fees and expenses; provided, however, that the omission to so
notify such Underwriter shall not relieve such Underwriter from any liability
which such Underwriter may have to the Company or any such person or otherwise.
The Company or such person shall have the right to employ its own counsel in any
such case, but the fees and expenses of such counsel shall be at the expense of
the Company or such person unless the employment of such counsel shall have been
authorized in writing by such Underwriter in connection with the defense of such
Proceeding or such Underwriter shall not have, within a reasonable period of
time in light of the circumstances, employed counsel to have charge of the
defense of such Proceeding or such indemnified party or parties shall have
reasonably concluded that there may be defenses available to it or them which
are different from or additional to or in conflict with those available to such
Underwriter (in which case such Underwriter shall not have the right to direct
the defense of such Proceeding on behalf of the indemnified party or parties,
but such Underwriter may employ counsel and participate in the defense thereof
but the fees and expenses of such counsel shall be at the expense of such
Underwriter), in any of which events such reasonable fees and expenses shall be
borne by such Underwriter and paid as incurred (it being understood, however,
that such Underwriter shall not be liable for the reasonable expenses of more
than one separate counsel (in addition to any local counsel) in any one
Proceeding or series of related Proceedings in the same jurisdiction
representing the indemnified parties who are parties to such Proceeding). No
Underwriter shall be liable for any settlement of any such Proceeding effected
without the written consent of such Underwriter but if settled with the written
consent of such Underwriter, such Underwriter agrees to indemnify and hold
harmless the Company and any such person from and against any loss or liability
by reason of such settlement. Notwithstanding the foregoing sentence, if at any
time an indemnified party shall have requested an indemnifying party to
reimburse the indemnified party for fees and expenses of counsel as contemplated
by the second sentence of this paragraph, then the indemnifying party agrees
that it shall be liable for any settlement of any Proceeding effected without
its written consent if (i) such settlement is entered into more than 60 business
days after receipt by such indemnifying party of the aforesaid request, (ii)
such indemnifying party shall not have reimbursed the indemnified party in
accordance with such request prior to the date of such settlement and (iii) such
indemnified party shall have given the indemnifying party at least 30 days'
prior notice of its intention to settle. No indemnifying party shall, without
the prior written consent of the indemnified party, effect any settlement of any
pending or threatened Proceeding in respect of which any indemnified party is or
could have been a party and indemnity could have been sought hereunder by such
indemnified party, unless such settlement includes an unconditional release of
such indemnified party from all liability on claims that are the subject matter
of such Proceeding.
(c) If the indemnification provided for in this Section 10 is unavailable
to an indemnified party under subsections (a) and (b) of this Section 10 in
respect of any losses, damages, expenses, liabilities or claims referred to
therein, then each applicable indemnifying party, in lieu of indemnifying such
indemnified party, shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, damages, expenses, liabilities or
claims (i) in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other hand
from the offering of the Shares or (ii) if the allocation provided by clause (i)
-21-
above is not permitted by applicable law, in such proportion as is appropriate
to reflect not only the relative benefits referred to in clause (i) above but
also the relative fault of the Company on the one hand and of the Underwriters
on the other in connection with the statements or omissions which resulted in
such losses, damages, expenses, liabilities or claims, as well as any other
relevant equitable considerations. The relative benefits received by the Company
on the one hand and the Underwriters on the other shall be deemed to be in the
same respective proportions as the total proceeds from the offering (net of
underwriting discounts and commissions but before deducting expenses) received
by the Company and the total underwriting discounts and commissions received by
the Underwriters, bear to the aggregate public offering price of the Shares. The
relative fault of the Company on the one hand and of the Underwriters on the
other shall be determined by reference to, among other things, whether the
untrue statement or alleged untrue statement of a material fact or omission or
alleged omission relates to information supplied by the Company or by the
Underwriters and the parties' relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The amount
paid or payable by a party as a result of the losses, damages, expenses,
liabilities and claims referred to in this subsection shall be deemed to include
any legal or other fees or expenses reasonably incurred by such party in
connection with investigating, preparing to defend or defending any Proceeding.
(d) The Company and the Underwriters agree that it would not be just and
equitable if contribution pursuant to this Section 10 were determined by pro
rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in subsection (c) above. Notwithstanding
the provisions of this Section 10, no Underwriter shall be required to
contribute any amount in excess of the amount by which the total price at which
the Shares underwritten by such Underwriter and distributed to the public were
offered to the public exceeds the amount of any damage which such Underwriter
has otherwise been required to pay by reason of such untrue statement or alleged
untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters' obligations to contribute pursuant to this
Section 10 are several in proportion to their respective underwriting
commitments and not joint.
(e) The indemnity and contribution agreements contained in this Section 10
and the covenants, warranties and representations of the Company contained in
this Agreement shall remain in full force and effect regardless of any
investigation made by or on behalf of any Underwriter, its partners, directors
or officers or any person (including each partner, officer or director of such
person) who controls any Underwriter within the meaning of Section 15 of the Act
or Section 20 of the Exchange Act, or by or on behalf of the Company, its
directors or officers or any person who controls the Company within the meaning
of Section 15 of the Act or Section 20 of the Exchange Act, and shall survive
any termination of this Agreement or the issuance and delivery of the Shares.
The Company and each Underwriter agree promptly to notify each other of the
commencement of any Proceeding against it and, in the case of the Company,
against any of the Company's officers or directors in connection with the
issuance and sale of the Shares, or in connection with the Registration
Statement or Prospectus.
11. Representations and Indemnities to Survive. The respective agreements,
representations, warranties, indemnities and other statements of the Company or
its officers and of the Underwriters set forth in or made pursuant to this
-22-
Agreement will remain in full force and effect, regardless of any investigation
made by or on behalf of any Underwriter or the Company or any of the officers,
directors or controlling persons referred to in Section 10 hereof, and will
survive delivery of and payment for the Shares. The provisions of Section 8 and
10 hereof and this Section 11 shall survive the termination or cancellation of
this Agreement.
12. Notices. All communications hereunder will be in writing and effective
only on receipt, and, if sent to the Representatives, will be mailed, delivered
by courier or facsimile and confirmed to them, at the address specified in
Schedule I hereto, with a copy to: [ ]; or, if sent to the Company, will be
mailed, delivered by courier or facsimile and confirmed to it at Aphton
Corporation, 00 X.X. 0xx Xxxxxx, Xxxxx, Xxxxxxx 331, Attention: Xxxx Xxxxx.
13. Successors. This Agreement will inure to the benefit of and be binding
upon the parties hereto and their respective successors and the officers and
directors and controlling persons referred to in Section 8 hereof, and no other
person will have any right or obligation hereunder.
14. Counterparts. This Agreement may be executed in any number of
counterparts, all of which shall constitute a single instrument.
15. Applicable Law. This Agreement will be governed by and construed in
accordance with the internal laws of the State of New York, without giving
effect to principles of conflict of laws.
-23-
If the foregoing is in accordance with your understanding of our agreement,
please sign and return to us the enclosed duplicate hereof, whereupon this
letter and your acceptance shall represent a binding agreement among the Company
and the several Underwriters.
Very truly yours,
APHTON CORPORATION
By:
---------------------------------
Name:
Title:
The foregoing Agreement is hereby confirmed
and accepted as of the date specified in
Schedule I hereto.
By: [Name of Representatives]
By:
-------------------------------------
Name:
Title:
For themselves and the other several
Underwriters, if any, named in Schedule II to
the foregoing Agreement.
-24-
SCHEDULE I
Underwriting Agreement dated ___________, ____
Registration Statement No. 333-
Representatives:
Address of Representatives:
Title, Purchase Price and Description of Shares:
Title:
Purchase price (include type of funds, if applicable): ____________ in
federal (same day) funds or wire transfer to an account previously designated to
the Representatives by the Company, or if agreed to by the Representatives and
the Company, by certified or official bank check or checks.
Other provisions:
Closing Date, Time and Location: ____________________
Delayed Delivery Arrangements:
Fee: ___________________
Minimum amount of each contract: ________________
Maximum aggregate amount of all contracts: ________________
Additional items to be covered by the letter
from Ernst & Young LLP delivered
pursuant to Section 6(f) at the
time this Agreement is executed: _____________________________
-25-
SCHEDULE II
Underwriters:
Principal Amount of Initial Shares to be Purchased:
-26-
SCHEDULE III
Subsidiaries
-27
SCHEDULE IV
Delayed Delivery Contract
[Date]
[Insert name and address
of lead Representative]
Dear Sirs:
The undersigned hereby agrees to purchase from Aphton Corporation, a
Delaware corporation (the "Company"), and the Company agrees to sell to the
undersigned, on , , (the "Delivery Date"), shares of the Company's Common Stock
(the "Shares") offered by the Company's Final Prospectus dated , 200_ , receipt
of a copy of which is hereby acknowledged, at a purchase price of , and on the
further terms and conditions set forth in this contract.
Payment for the Shares to be purchased by the undersigned shall be made on
or before 11:00 A.M. on the Delivery Date to or upon the order of the Company in
New York Clearing House (next day) funds, at your office or at such other place
as shall be agreed between the Company and the undersigned upon delivery to the
undersigned of the Shares in definitive fully registered form and in such
authorized denominations and registered in such names as the undersigned may
request by written or telegraphic communication addressed to the Company not
less than five full business days prior to the Delivery Date. If no request is
received, the Shares will be registered in the name of the undersigned and
issued in a denomination equal to the aggregate amount of Shares to be purchased
by the undersigned on the Delivery Date.
The obligation of the undersigned to take delivery of and make payment for
Shares on the Delivery Date, and the obligation of the Company to sell and
deliver Shares on the Delivery Date, shall be subject to the conditions (and
neither party shall incur any liability by reason of the failure thereof) that
(1) the purchase of Shares to be made by the undersigned, which purchase the
undersigned represents is not prohibited on the date hereof, shall not on the
Delivery Date be prohibited under the laws of the jurisdiction to which the
undersigned is subject, and (2) the Company, on or before the Delivery Date,
shall have sold to certain underwriters (the "Underwriters") such amount of the
Shares as is to be sold to them pursuant to the Underwriting Agreement referred
to in the Final Prospectus mentioned above. Promptly after completion of such
sale to the Underwriters, the Company will mail or deliver to the undersigned at
its address set forth below notice to such effect, accompanied by a copy of the
opinion of counsel for the Company delivered to the Underwriters in connection
therewith. The obligation of the undersigned to take delivery of and make
payment for the Shares, and the obligation of the Company to cause the Shares to
be sold and delivered, shall not be affected by the failure of any purchaser to
take delivery of and make payment for the Shares pursuant to other contracts
similar to this contract.
-28-
This contract will inure to the benefit of and be binding upon the parties
hereto and their respective successors, but will not be assignable by either
party hereto without the written consent of the other.
It is understood that acceptance of this contract and other similar
contracts is in the Company's sole discretion and, without limiting the
foregoing, need not be on the first come, first served basis. If this contract
is acceptable to the Company, it is required that the Company sign the form of
acceptance below and mail or deliver one of the counterparts hereof to the
undersigned at its address set forth below. This will become a binding contract
between the Company and the undersigned, as of the date first above written,
when such counterpart is so mailed or delivered.
This agreement shall be governed by and construed in accordance with the
internal laws of the State of New York, without giving effect to principles of
conflict of laws.
Very truly yours,
-----------------------------------------
(Name of Purchaser)
By:
--------------------------------------
(Signature and Title of Officer)
--------------------------------------
(Address)
Accepted:
APHTON CORPORATION
By:
-----------------------------
(Authorized Signature)
-29-
SCHEDULE V
__________ Shares
Aphton Corporation
(a Delaware corporation)
Common Stock
$0.001 par value
PRICING AGREEMENT
[Date]
as Representative of the several Underwriters
Dear Sirs:
Reference is made to the Underwriting Agreement, dated _____________ __,
___ (the "Underwriting Agreement"), relating to the purchase by the several
Underwriters named in Schedule I thereto, for whom you are acting as
representatives (the "Representatives"), of the above shares of Common Stock
(the "Initial Shares"), of Aphton Corporation, a Delaware corporation (the
"Company").
We confirm that the Closing Date (as defined in Section 2 of the
Underwriting Agreement) shall be at 9:30 A.M., New York City time, on __________
__, 200__ at the offices of [ ].
Pursuant to Section 2 of the Underwriting Agreement, the Company agrees
with each Underwriter as follows:
1. The initial public offering price per share for the Initial Shares,
determined as provided in said Section 2, shall be $__.__.
2. The purchase price per share for the Initial Shares to be paid by the
several Underwriters shall be $__.__, being an amount equal to the initial
public offering price set forth above less $_.__ per share.
If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Company a counterpart hereof, whereupon this
-30-
instrument, along with all counterparts, will become a binding agreement between
the Underwriters and the Company in accordance with its terms.
Very truly yours,
APHTON CORPORATION
By:
--------------------------------------
Name:
Title:
CONFIRMED AND ACCEPTED:
As of the date first above written:
By:
By:
----------------------------------------
Name:
Title:
For themselves and as Representatives of the other Underwriters named in Annex A
hereto.
-31-
ANNEX A
-32-
EXHIBIT A
[Date]
[To the Representatives
Named in Schedule I of the Agreement]
Re: Aphton Corporation
Ladies and Gentlemen:
We have acted as special counsel for Aphton Corporation, a Delaware
corporation ("the Company"), in connection with (i) the execution and delivery
of an Underwriting Agreement, dated [___________] (the "Underwriting
Agreement"), among the Company, and [_______________________________], (the
"Underwriters"), providing for the purchase by the Underwriters from the
Company, upon the terms and conditions set forth in the Underwriting Agreement,
of an aggregate of [_____________] shares of the Company's common stock, par
value $.001 per share (the "Shares"), and (ii) the preparation and filing by the
Company with the Securities and Exchange Commission (the "Commission") under the
Securities Act of 1933, as amended (the "Act") of the Registration Statement on
Form S-3 (File No. ______________). As described in the Prospectus, the
Company's Annual Report on Form 10-K/A for the year ended __________, its
Quarterly Report(s) on Form 10-Q for the months ended _______________, its
Current Report(s) on Form 8-K dated ______________________________, and the
description of the Company's common stock contained in the Company's
Registration Statement on Form 8-A, filed with the Commission on January 30,
1998 (collectively, the "Incorporated Documents"), are incorporated in the
Prospectus by reference.
In so acting, we have examined such certificates of public officials, and
certificates of officers of the Company, and the originals (or copies thereof
certified to our satisfaction) of such corporate documents and records of the
Company, and such other documents, records and papers as we have deemed relevant
in order to give the opinions hereinafter set forth. In this connection, we have
assumed the genuineness of signatures on, the authenticity of all documents
submitted to us as originals and the conformity to authentic original documents
of all documents submitted to us as certified, conformed or photostatic copies.
Also, we have relied upon such certificates of public officials, and officers of
the Company and such other certifications with respect to the accuracy of
material factual matters contained therein which were not independently
established. We did not participate in the preparation of the Incorporated
Documents or review any of them prior to their being filed with the Commission
under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), but
we did review them in connection with our participation in the preparation of
the Prospectus.
-33-
Based upon and subject to the foregoing, it is our opinion that:
1. The Company has been duly incorporated and is validly existing as a
corporation in corporate good standing under the laws of the State of
Delaware and has the corporate power and authority to own, lease and
operate its properties and conduct its business as described in the
Registration Statement, to enter into the Underwriting Agreement, to issue,
sell and deliver the Shares and to consummate the transactions contemplated
in the Prospectus.
2. The Common Stock of the Company, including the Shares, conforms in
all material respects to the description thereof contained in the
Registration Statement and the Prospectus.
3. The Shares have been duly and validly authorized by the Company for
offer, sale, issuance and delivery pursuant to the Underwriting Agreement
and, when issued and delivered against payment therefor as provided in the
Underwriting Agreement, will be duly and validly issued and fully paid and
non-assessable.
4. To our knowledge and other than as set forth in the Prospectus,
there is no legal or governmental proceeding threatened in writing or
pending in any state or federal court to which the Company is a party or to
which any property of the Company is subject, which could prevent
consummation of the transactions contemplated by the Underwriting
Agreement.
5. The Underwriting Agreement has been duly authorized, executed and
delivered by the Company.
6. The execution, delivery and performance of the Underwriting
Agreement, the issuance and sale of the Shares and the consummation of the
transactions contemplated by the Underwriting Agreement will not conflict
with, or result in any breach of or constitute a default under (nor
constitute any event which with notice, lapse of time, or both would result
in any breach of, or constitute a default under), (i) any provisions of the
charter or by-laws of the Company or, (ii) under any provision of any
license, indenture, mortgage, deed of trust, bank loan or credit agreement
or other evidence of indebtedness, or any lease, contract or other
agreement or instrument to which the Company is a party or by which it or
its property may be bound or affected and which have been filed by the
Company with the Commission under the Exchange Act, and are listed in the
exhibit index to the Company's most recent Annual Report on Form 10-K/A or
were subsequently filed prior to the date hereof under the Exchange Act, or
(iii) under any decree, judgment or order known to us to be applicable to
the Company or under any U.S. Federal or New York State law, regulation or
rule which in our experience are normally applicable to transactions of the
type contemplated by the Underwriting Agreement, except in the case of
clauses (ii) and (iii) for such conflicts, breaches, or defaults,
individually or in the aggregate, as would not reasonably be expected to
have a material adverse effect on the business, properties, prospects,
financial condition or results of operation of the Company taken as a whole
.
-34-
7. No approval, authorization, consent or order of or filing with any
New York State or U.S. Federal governmental agency or body or any New York
State or U.S. Federal court is required to be obtained or made by the
Company for the issuance and sale of the Shares or the consummation by the
Company of the transactions as contemplated by the Underwriting Agreement
except such as may be required by the Act and the applicable rules and
regulations thereunder, the securities or blue sky laws of the various
jurisdictions in which the Shares are being offered by the Underwriters (as
to which we express no opinion) or under the rules and regulations of the
National Association of Securities Dealers, Inc. (as to which we express no
opinion).
8. The Company is not and, after giving effect to the offering and
sale of the Shares, will not be required to register as an "investment
company" as such term is defined in the Investment Company Act of 1940, as
amended.
In passing upon the form of the Registration Statement and the Prospectus,
we necessarily have assumed the accuracy and completeness of the information
included or incorporated by reference therein by the Company and the
responsiveness to the applicable forms, rules and regulations of the Commission
promulgated under the Exchange Act of the information included in the
Incorporated Documents by the Company and we take no responsibility therefor.
Based upon such assumptions, in our opinion the Registration Statement, as of
its effective date, and the Prospectus, as of its date (except in each case for
the financial statements and schedules and other financial and statistical data
contained or incorporated by reference therein or omitted therefrom, as to which
we express no opinion), appeared on their face to comply as to form in all
material respects with the requirements of the Act and the rules and regulations
of the Commission thereunder.
In the course of the preparation by the Company of the Registration
Statement and the Prospectus (other than the Incorporated Documents), we have
participated in conferences with certain officers of the Company, with
representatives of the independent auditors of the Company, and with you and
your counsel. Based upon such participation in the preparation of the
Registration Statement and the Prospectus (other than the Incorporated
Documents), and our review and discussion of the contents thereof, but without
independent check or verification except as otherwise specified above, nothing
has come to our attention which causes us to believe that the Registration
Statement, as of its effective date, or the Prospectus, as of its date, (except
in each case for the financial statements and schedules and other financial or
statistical data contained or incorporated by reference therein or omitted
therefrom as to which we express no belief), contained any untrue statement of a
material fact or omitted therefrom to state any material fact required to be
stated therein or necessary to make the statements therein (in the case of the
Prospectus, in the light of the circumstances under which they were made) not
misleading.
The opinions expressed above are limited to questions arising under the
Federal Law of the United States, the General Corporation Law of the State of
Delaware and the law of the State of New York. This opinion may not be relied
upon by or published or communicated to any person and may not be used for any
other purpose whatsoever without prior written approval in each instance.
Very truly yours,
-35-
